|1.||Gegenhuber, Alfons: 1 article (06/2010)|
|2.||Haltmayer, Meinhard: 1 article (06/2010)|
|3.||Kaar, Gerhard: 1 article (06/2010)|
|4.||Dieplinger, Benjamin: 1 article (06/2010)|
|5.||Mueller, Thomas: 1 article (06/2010)|
|6.||Poelz, Werner: 1 article (06/2010)|
|7.||Narayan, Hafid: 1 article (03/2010)|
|8.||Ng, Leong L: 1 article (03/2010)|
|9.||Quinn, Paulene A: 1 article (03/2010)|
|10.||Davies, Joan E: 1 article (03/2010)|
|1.||Hypertension (High Blood Pressure)
03/01/2007 - "Futhermore, we tested 17 individuals with hypertension and found that probands with anamnesi of hypertension had higher proguanylin values than healthy individuals from the first study (medians 16.2 vs. 11.3 ng/ml, p < 0.01). "
03/01/2007 - "Further research is necessary to confirm our findings in individuals with hypertension with different medication in order to assess proguanylin value as a risk predictor of accelerated hypertension, and to classify individuals with hypertension for variuos types of diuretic therapy."
03/01/2010 - "In multivariate analysis, a history of hypertension and low eGFR both had strong independent associations with proguanylin and prouroguanylin levels. "
03/01/2007 - "The pilot study supports the hypothesis about the role of proguanylin in sodium metabolism and its possible importance for hypertension disorder. "
03/01/2007 - "The aim of our work was to develop an assay for the determination of proguanylin in human blood, and investigate its levels in healthy volunteers and donors suffer from hypertension often accompanied by body sodium accumulation and plasma volume expansion. "
01/01/2003 - "Proguanylin and prouroguanylin circulate in blood and bind to receptors in intestine, kidney, liver, brain etc. In the kidney, they stimulate the excretion of Na+ and K+. Study of GC-C "knock-out" mice reveal that GC-C is important to intestinal salt and water secretion, duodenal bicarbonate secretion, recovery from CCl4-induced liver injury, and to intestinal polyp formation in Min mice lacking GC-C."
|3.||Renal Insufficiency (Renal Failure)
|5.||Dyspnea (Shortness of Breath)
06/01/2010 - "We measured 10 biomarkers [B-type natriuretic peptide (BNP), midregional pro-A-type natriuretic peptide (MR-proANP), midregional-proadrenomedullin (MR-proADM), copeptin, C-terminal endothelin-1 precursor fragment (CT-proET-1), soluble ST2 (sST2), chromogranin A (CgA), adiponectin, proguanylin, and prouroguanylin] in 251 consecutive patients with acute dyspnea presenting to the emergency department of a tertiary care hospital. "
|4.||Brain Natriuretic Peptide (Natrecor)
|5.||Endothelin-1 (Endothelin 1)
|6.||Biological Markers (Surrogate Marker)